Loading...
Hisamitsu Pharmaceutical Co., Inc.
HTSUY•PNK
Healthcare
Medical - Pharmaceuticals
$6.79
$0.00(0.00%)
Hisamitsu Pharmaceutical Co., Inc. (HTSUY) Financial Performance & Income Statement Overview
Review Hisamitsu Pharmaceutical Co., Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-99.28%
↓ 99.28%
Operating Income Growth
-99.06%
↓ 99.06%
Net Income Growth
-98.98%
↓ 98.98%
Operating Cash Flow Growth
-99.32%
↓ 99.32%
Operating Margin
12.25%
↑ 12.25%
Gross Margin
59.51%
↑ 59.51%
Net Profit Margin
0.35%
↑ 0.35%
ROE
7.99%
↑ 7.99%
ROIC
252.10%
↑ 252.10%
Hisamitsu Pharmaceutical Co., Inc. (HTSUY) Income Statement & Financial Overview
Review Hisamitsu Pharmaceutical Co., Inc.'s (HTSUY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $290.57M | $240.37M | $39.65B | $233.57M |
| Cost of Revenue | $129.50M | $92.79M | $16.04B | $97.87M |
| Gross Profit | $161.07M | $147.59M | $23.60B | $135.70M |
| Gross Profit Ratio | $0.55 | $0.61 | $0.60 | $0.58 |
| R&D Expenses | $0.00 | $0.00 | $17.89M | $15.35M |
| SG&A Expenses | $124.23M | $119.29M | $0.00 | $93.28M |
| Operating Expenses | $124.23M | $119.29M | $18.75B | $108.63M |
| Total Costs & Expenses | -$253.73M | -$212.08M | $34.79B | $206.50M |
| Interest Income | $3.74M | $4.77M | $4.76M | $4.75M |
| Interest Expense | $51942.00 | $0.00 | $77994.00 | $26089.00 |
| Depreciation & Amortization | $11.88M | $10.18M | $10.24M | $9.22M |
| EBITDA | $72.16M | $52.52M | $6.20B | $54.35M |
| EBITDA Ratio | $0.25 | $0.22 | $0.16 | $0.23 |
| Operating Income | $36.85M | $28.30M | $4.86B | $27.07M |
| Operating Income Ratio | $0.13 | $0.12 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | $23.37M | $14.08M | -$4.82B | $18.03M |
| Income Before Tax | $60.22M | $42.38M | $40.21M | $45.10M |
| Income Before Tax Ratio | $0.21 | $0.18 | $0.001 | $0.19 |
| Income Tax Expense | $6.72M | $11.08M | $11.41M | $12.68M |
| Net Income | $52.58M | $30.63M | $28.007M | $31.24M |
| Net Income Ratio | $0.18 | $0.13 | $0.001 | $0.13 |
| EPS | $0.18 | $0.11 | $14.69 | $0.10 |
| Diluted EPS | $0.18 | $0.10 | $14.68 | $0.10 |
| Weighted Avg Shares Outstanding | $292.92M | $291.74M | $293.37M | $299.77M |
| Weighted Avg Shares Outstanding (Diluted) | $292.92M | $293.32M | $293.51M | $300.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan